These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 6173118
1. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology. Canellos GP, Skarin AT, Rosenthal DS, Moloney WC, Frei E. Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118 [Abstract] [Full Text] [Related]
2. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies. Anderson KC, Skarin AT, Rosenthal DS, MacIntyre JM, Pinkus GS, Case DC, Leonard RC, Canellos GP. Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007 [Abstract] [Full Text] [Related]
3. The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma. Canellos GP, Skarin AT, Klatt MM, Rosenthal DS, Case DC, Pinkus GS, Jochelson MS, Yeap BY, Shipp MA. Semin Hematol; 1987 Apr; 24(2 Suppl 1):2-7. PubMed ID: 2438777 [Abstract] [Full Text] [Related]
6. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma]. Sampi K, Hattori M. Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194 [Abstract] [Full Text] [Related]
13. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M. Srp Arh Celok Lek; 1998 Jul; 126(9-10):345-8. PubMed ID: 9863405 [Abstract] [Full Text] [Related]
14. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study. Longo DL, Duffey PL, Gribben JG, Jaffe ES, Curti BD, Gause BL, Janik JE, Braman VM, Esseltine D, Wilson WH, Kaufman D, Wittes RE, Nadler LM, Urba WJ. Cancer J; 2000 Jul; 6(3):146-50. PubMed ID: 10882329 [Abstract] [Full Text] [Related]
18. Combination chemotherapy with VM-26, adriamycin bleomycin, and prednisone as a secondary treatment of malignant lymphoma. Goldhirsch A, Pirovino M, Sonntag RW, Tschopp L, Ryssel HJ, Brunner KW. Cancer Treat Rep; 1980 Jul; 64(2-3):335-7. PubMed ID: 6157468 [Abstract] [Full Text] [Related]
19. Methotrexate-citrovorum factor used alone and in combination chemotherapy for advanced hypernephromas. Baumgartner G, Heinz R, Arbes H, Lenzhofer R, Pridun N, Schüller J. Cancer Treat Rep; 1980 Jan; 64(1):41-6. PubMed ID: 6155211 [Abstract] [Full Text] [Related]
20. A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851. Ginsberg SJ, Anderson JR, Gottlieb AJ, Bloomfield CD, Norton L, Barcos M, Holland JF. NCI Monogr; 1987 Jan; (5):77-80. PubMed ID: 2448657 [Abstract] [Full Text] [Related] Page: [Next] [New Search]